Metformin, the most commonly used drug to treat type 2 diabetes, not only lowers blood sugar levels but has revealed to extend lifespan in C. Elegans — an animal model that shares similar metabolic systems with humans and are often used to model human diseases.
Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome – Biotech Investments
Issuer: Immunic AG / Key word(s): Study 04.09.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Announces First